Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer.

Goncalves R, DeSchryver K, Ma C, Tao Y, Hoog J, Cheang M, Crouch E, Dahiya N, Sanati S, Barnes M, Sarian LOZ, Olson J, Allred DC, Ellis MJ.

Breast Cancer Res Treat. 2017 Sep;165(2):355-364. doi: 10.1007/s10549-017-4329-y. Epub 2017 Jun 13.

2.

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).

Ellis MJ, Suman VJ, Hoog J, Goncalves R, Sanati S, Creighton CJ, DeSchryver K, Crouch E, Brink A, Watson M, Luo J, Tao Y, Barnes M, Dowsett M, Budd GT, Winer E, Silverman P, Esserman L, Carey L, Ma CX, Unzeitig G, Pluard T, Whitworth P, Babiera G, Guenther JM, Dayao Z, Ota D, Leitch M, Olson JA Jr, Allred DC, Hunt K.

J Clin Oncol. 2017 Apr 1;35(10):1061-1069. doi: 10.1200/JCO.2016.69.4406. Epub 2017 Jan 3.

3.

Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers.

Miller CA, Gindin Y, Lu C, Griffith OL, Griffith M, Shen D, Hoog J, Li T, Larson DE, Watson M, Davies SR, Hunt K, Suman VJ, Snider J, Walsh T, Colditz GA, DeSchryver K, Wilson RK, Mardis ER, Ellis MJ.

Nat Commun. 2016 Aug 9;7:12498. doi: 10.1038/ncomms12498.

4.

PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance).

Liu MC, Pitcher BN, Mardis ER, Davies SR, Friedman PN, Snider JE, Vickery TL, Reed JP, DeSchryver K, Singh B, Gradishar WJ, Perez EA, Martino S, Citron ML, Norton L, Winer EP, Hudis CA, Carey LA, Bernard PS, Nielsen TO, Perou CM, Ellis MJ, Barry WT.

NPJ Breast Cancer. 2016;2. pii: 15023. doi: 10.1038/npjbcancer.2015.23. Epub 2016 Jan 6.

5.

Whole Exome Sequencing Reveals the Order of Genetic Changes during Malignant Transformation and Metastasis in a Single Patient with NF1-plexiform Neurofibroma.

Hirbe AC, Dahiya S, Miller CA, Li T, Fulton RS, Zhang X, McDonald S, DeSchryver K, Duncavage EJ, Walrath J, Reilly KM, Abel HJ, Pekmezci M, Perry A, Ley TJ, Gutmann DH.

Clin Cancer Res. 2015 Sep 15;21(18):4201-11. doi: 10.1158/1078-0432.CCR-14-3049. Epub 2015 Apr 29.

6.

Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts.

Li S, Shen D, Shao J, Crowder R, Liu W, Prat A, He X, Liu S, Hoog J, Lu C, Ding L, Griffith OL, Miller C, Larson D, Fulton RS, Harrison M, Mooney T, McMichael JF, Luo J, Tao Y, Goncalves R, Schlosberg C, Hiken JF, Saied L, Sanchez C, Giuntoli T, Bumb C, Cooper C, Kitchens RT, Lin A, Phommaly C, Davies SR, Zhang J, Kavuri MS, McEachern D, Dong YY, Ma C, Pluard T, Naughton M, Bose R, Suresh R, McDowell R, Michel L, Aft R, Gillanders W, DeSchryver K, Wilson RK, Wang S, Mills GB, Gonzalez-Angulo A, Edwards JR, Maher C, Perou CM, Mardis ER, Ellis MJ.

Cell Rep. 2013 Sep 26;4(6):1116-30. doi: 10.1016/j.celrep.2013.08.022. Epub 2013 Sep 19.

7.

Whole-genome analysis informs breast cancer response to aromatase inhibition.

Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, Van Tine BA, Hoog J, Goiffon RJ, Goldstein TC, Ng S, Lin L, Crowder R, Snider J, Ballman K, Weber J, Chen K, Koboldt DC, Kandoth C, Schierding WS, McMichael JF, Miller CA, Lu C, Harris CC, McLellan MD, Wendl MC, DeSchryver K, Allred DC, Esserman L, Unzeitig G, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Leitch M, Hunt K, Olson J, Tao Y, Maher CA, Fulton LL, Fulton RS, Harrison M, Oberkfell B, Du F, Demeter R, Vickery TL, Elhammali A, Piwnica-Worms H, McDonald S, Watson M, Dooling DJ, Ota D, Chang LW, Bose R, Ley TJ, Piwnica-Worms D, Stuart JM, Wilson RK, Mardis ER.

Nature. 2012 Jun 10;486(7403):353-60. doi: 10.1038/nature11143.

8.

Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031.

Ellis MJ, Suman VJ, Hoog J, Lin L, Snider J, Prat A, Parker JS, Luo J, DeSchryver K, Allred DC, Esserman LJ, Unzeitig GW, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Watson MA, Leitch M, Hunt K, Olson JA.

J Clin Oncol. 2011 Jun 10;29(17):2342-9. doi: 10.1200/JCO.2010.31.6950. Epub 2011 May 9.

9.

Epimorphin deletion protects mice from inflammation-induced colon carcinogenesis and alters stem cell niche myofibroblast secretion.

Shaker A, Swietlicki EA, Wang L, Jiang S, Onal B, Bala S, DeSchryver K, Newberry R, Levin MS, Rubin DC.

J Clin Invest. 2010 Jun;120(6):2081-93. doi: 10.1172/JCI40676. Epub 2010 May 10.

10.

Genome remodelling in a basal-like breast cancer metastasis and xenograft.

Ding L, Ellis MJ, Li S, Larson DE, Chen K, Wallis JW, Harris CC, McLellan MD, Fulton RS, Fulton LL, Abbott RM, Hoog J, Dooling DJ, Koboldt DC, Schmidt H, Kalicki J, Zhang Q, Chen L, Lin L, Wendl MC, McMichael JF, Magrini VJ, Cook L, McGrath SD, Vickery TL, Appelbaum E, Deschryver K, Davies S, Guintoli T, Lin L, Crowder R, Tao Y, Snider JE, Smith SM, Dukes AF, Sanderson GE, Pohl CS, Delehaunty KD, Fronick CC, Pape KA, Reed JS, Robinson JS, Hodges JS, Schierding W, Dees ND, Shen D, Locke DP, Wiechert ME, Eldred JM, Peck JB, Oberkfell BJ, Lolofie JT, Du F, Hawkins AE, O'Laughlin MD, Bernard KE, Cunningham M, Elliott G, Mason MD, Thompson DM Jr, Ivanovich JL, Goodfellow PJ, Perou CM, Weinstock GM, Aft R, Watson M, Ley TJ, Wilson RK, Mardis ER.

Nature. 2010 Apr 15;464(7291):999-1005. doi: 10.1038/nature08989.

11.

Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer.

Ellis MJ, Lin L, Crowder R, Tao Y, Hoog J, Snider J, Davies S, DeSchryver K, Evans DB, Steinseifer J, Bandaru R, Liu W, Gardner H, Semiglazov V, Watson M, Hunt K, Olson J, Baselga J.

Breast Cancer Res Treat. 2010 Jan;119(2):379-90. doi: 10.1007/s10549-009-0575-y.

12.

Early stage gastric cancer.

Weinstock L, Brunt LM, Ritter J, Deschryver K.

Gastrointest Endosc. 2003 Mar;57(3):385. No abstract available.

PMID:
12612523
13.

Xanthoma of the colon.

Weinstock LB, Shatz BA, Saltman RJ, Deschryver K.

Gastrointest Endosc. 2002 Mar;55(3):410. No abstract available.

PMID:
11868018
14.

Fibrous Lesions of the Breast: A Review.

McMenamin ME, DeSchryver K, Fletcher CD.

Int J Surg Pathol. 2000 Apr;8(2):99-108.

PMID:
11493974
15.

Pathology of the breast in children, adolescents, and young adults.

Dehner LP, Hill DA, Deschryver K.

Semin Diagn Pathol. 1999 Aug;16(3):235-47. Review.

PMID:
10490200
16.

Pathology of large-caliber stereotactic biopsies in nonpalpable breast lesions.

Deschryver K, Radford DM, Schuh ME.

Semin Diagn Pathol. 1999 Aug;16(3):224-34.

PMID:
10490199
17.

Sequence-ready contig for the 1.4-cM ductal carcinoma in situ loss of heterozygosity region on chromosome 8p22-p23.

Wang JC, Radford DM, Holt MS, Helms C, Goate A, Brandt W, Parik M, Phillips NJ, DeSchryver K, Schuh ME, Fair KL, Ritter JH, Marshall P, Donis-Keller H.

Genomics. 1999 Aug 15;60(1):1-11.

PMID:
10458905
18.

Colonic mucosal speckling detected by endoscopy: histopathologic differential diagnosis.

Weinstock LB, Shatz BA, Thyssen EP, Ritter JH, Korenblat PE, Deschryver K.

Gastrointest Endosc. 1999 Jun;49(6):786-90. No abstract available.

PMID:
10343230
19.

Colonic chicken skin mucosa: an endoscopic and histological abnormality adjacent to colonic neoplasms.

Shatz BA, Weinstock LB, Thyssen EP, Mujeeb I, DeSchryver K.

Am J Gastroenterol. 1998 Apr;93(4):623-7.

PMID:
9576459
20.
21.

Surgical therapy in two patients with pedunculated hepatocellular carcinoma.

Moritz MW, Shoji M, Sicard GA, Shioda R, DeSchryver K.

Arch Surg. 1988 Jun;123(6):772-4. Review.

PMID:
2835943
22.

Arachidonate lipoxygenase products and renal allograft rejection in dogs.

Mangino MJ, Anderson CB, Deschryver K, Turk J.

Transplantation. 1987 Dec;44(6):805-8.

PMID:
2827351
23.

Arachidonic acid metabolism and renal allograft rejection.

Mangino MJ, Anderson CB, DeSchryver K, Tyler JD, Sicard GA, Turk JW.

Transplant Proc. 1987 Feb;19(1 Pt 1):444-5. No abstract available.

PMID:
3274801
24.

Benign extrinsic compression of the common bile duct: a case report.

Downey RS, Sicard GA, Lee JT, DeSchryver K, Anderson CB.

Surgery. 1986 Jul;100(1):113-7.

PMID:
3726752
25.

So-called glandular schwannoma: ependymal differentiation in a case.

DeSchryver K, Santa Cruz DJ.

Ultrastruct Pathol. 1984;6(2-3):167-75.

PMID:
6087524
27.

Presence of inflammatory cells associated with exaggerated arachidonic acid metabolism in renal injury.

Jonas PE, DeSchryver K, Okegawa T, Leahy K, Needleman P.

Adv Prostaglandin Thromboxane Leukot Res. 1983;12:65-73.

PMID:
6221640
28.

Clinical and histologic indications for extensive pancreatic resection in nesidioblastosis.

Kramer JL, Bell MJ, DeSchryver K, Bower RJ, Ternberg JL, White NH.

Am J Surg. 1982 Jan;143(1):116-9.

PMID:
7032331
29.

Acromegaly and Cushing's syndrome associated with a foregut carcinoid tumor.

Leveston SA, McKeel DW Jr, Buckley PJ, Deschryver K, Greider MH, Jaffe BM, Daughaday WH.

J Clin Endocrinol Metab. 1981 Oct;53(4):682-9.

PMID:
6270170

Supplemental Content

Loading ...
Support Center